These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25619056)

  • 1. Earlier screening for life-threatening conditions in babies.
    Community Pract; 2014 Oct; 87(10):5. PubMed ID: 25619056
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormality screening. 'Should be earlier for serious cases'.
    Midwives; 2014; 17(5):8-9. PubMed ID: 25328964
    [No Abstract]   [Full Text] [Related]  

  • 3. Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond.
    Allyse M; Chandrasekharan S
    Genet Med; 2015 Dec; 17(12):958-61. PubMed ID: 25790161
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values.
    Wax JR; Chard R; Cartin A; Litton C; Pinette MG; Lucas FL
    Am J Obstet Gynecol; 2015 Apr; 212(4):548-9. PubMed ID: 25555658
    [No Abstract]   [Full Text] [Related]  

  • 5. Microarray analysis: elegant, accurate, and expensive.
    Wenstrom KD
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):199-201. PubMed ID: 25004356
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of low molecular weight heparin medication on plasma DNA in pregnant women.
    Grömminger S; Erkan S; Schöck U; Stangier K; Bonnet J; Schloo R; Schubert A; Prott EC; Knoll U; Stumm M; von Kalle C; Hofmann W
    Prenat Diagn; 2015 Nov; 35(11):1155-7. PubMed ID: 26248743
    [No Abstract]   [Full Text] [Related]  

  • 7. Antenatal detection of Edwards (Trisomy 18) and Patau (Trisomy 13) syndrome: England and Wales 2005-2012.
    Springett AL; Morris JK
    J Med Screen; 2014 Sep; 21(3):113-9. PubMed ID: 24993362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?
    Grati FR; Malvestiti F; Grimi B; Liuti R; Agrati C; Gaetani E; Milani S; Martinoni L; Zanatta V; Gallazzi G; Maggi F; Simoni G
    Prenat Diagn; 2015 Mar; 35(3):308-9. PubMed ID: 25754154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trisomy 18 and 13 and triploidy: the best way to diagnosis].
    Odeh M
    Harefuah; 2014 Sep; 153(9):522-3, 559. PubMed ID: 25417487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
    Hume H; Chasen ST
    Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflex antenatal DNA screening for Down syndrome.
    Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
    Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
    [No Abstract]   [Full Text] [Related]  

  • 14. Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.
    Haug S; Goldstein M; Cummins D; Fayard E; Merritt TA
    JAMA Pediatr; 2017 Apr; 171(4):382-387. PubMed ID: 28192554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of trisomy 21, 18 and 13 by quantitative pyrosequencing of segmental duplications.
    Tong H; Jin Y; Xu Y; Zou B; Ye H; Wu H; Kumar S; Pitman JL; Zhou G; Song Q
    Clin Genet; 2016 Nov; 90(5):451-455. PubMed ID: 26948280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utility.
    Hui L
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):2-6. PubMed ID: 23280734
    [No Abstract]   [Full Text] [Related]  

  • 17. Antenatal screening for Down's syndrome, trisomy 18, and trisomy 13: Reporting a single screening result for all three.
    Bestwick JP; Wald NJ
    J Med Screen; 2015 Jun; 22(2):100-5. PubMed ID: 25872932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of de novo secondary trisomy 13 due to isochromosome (13q;13q) of paternal origin in a pregnancy with fetal cystic hygroma.
    Chen CP; Ko TM; Huang MC; Chern SR; Lin TW; Chang TY; Kuo YL; Chen WL; Wang W
    Taiwan J Obstet Gynecol; 2015 Feb; 54(1):78-80. PubMed ID: 25675926
    [No Abstract]   [Full Text] [Related]  

  • 19. Revised estimates of the risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18.
    Cavadino A; Morris JK
    Am J Med Genet A; 2017 Apr; 173(4):953-958. PubMed ID: 28328132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.